Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Beta blocker
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Comparative information == === Pharmacological differences === * Agents with intrinsic sympathomimetic action (ISA) ** Acebutolol,<ref name="BB in HTN Meta-analyses">{{cite journal | vauthors = Larochelle P, Tobe SW, Lacourcière Y | title = β-Blockers in hypertension: studies and meta-analyses over the years | journal = The Canadian Journal of Cardiology | volume = 30 | issue = 5 Suppl | pages = S16–S22 | date = May 2014 | pmid = 24750978 | doi = 10.1016/j.cjca.2014.02.012 | doi-access = free }}</ref> pindolol,<ref name="BB in HTN Meta-analyses" /> labetalol,<ref name="BB in HTN Meta-analyses" /> mepindolol,<ref>{{cite book| veditors = Ganten D, Mulrow PJ |title=Pharmacology of Antihypertensive Therapeutics |date=1990 |publisher=Springer Berlin Heidelberg|location=Berlin, Heidelberg|isbn=9783642742095|page=523}}</ref> oxprenolol,<ref name="oxprenolol" /> celiprolol,<ref name="Celiprolol" /> penbutolol<ref name="PharmLetter BB Table" /> * Agents organized by lipid solubility (lipophilicity)<ref>{{cite journal | vauthors = Zipursky JS, Macdonald EM, Luo J, Gomes T, Mamdani MM, Paterson JM, Juurlink DN | title = Lipophilic β-Blockers and Suicide in the Elderly | journal = Journal of Clinical Psychopharmacology | volume = 37 | issue = 3 | pages = 381–384 | date = June 2017 | pmid = 28338548 | doi = 10.1097/JCP.0000000000000695 | s2cid = 23355130 }}</ref> ** High lipophilicity: propranolol, labetalol ** Intermediate lipophilicity: metoprolol, bisoprolol, carvedilol, acebutolol, timolol, pindolol ** Low lipophilicity (also known as hydrophilic beta blockers): atenolol, nadolol, and sotalol * Agents with [[membrane stabilizing effect]]<ref name="Aronson">{{cite journal | vauthors = Aronson JK | title = Changing beta-blockers in heart failure: when is a class not a class? | journal = The British Journal of General Practice | volume = 58 | issue = 551 | pages = 387–389 | date = June 2008 | pmid = 18505613 | pmc = 2418988 | doi = 10.3399/bjgp08X299317 }}</ref> ** Carvedilol, propranolol > oxprenolol > labetalol, metoprolol, timolol === Indication differences === * Agents specifically labeled for cardiac arrhythmia ** [[Esmolol]],<ref name="Esmolol package insert">{{Cite web |title=DailyMed - BREVIBLOC- esmolol hydrochloride injection |url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=595cc3d5-1306-4828-aefa-5595219ffd62 |access-date=2022-11-09 | work = DailyMed | publisher = U.S. National Library of Medicine }}</ref> [[sotalol]],<ref>{{Cite web |title=DailyMed - BETAPACE- sotalol hydrochloride tablet BETAPACE AF- sotalol hydrochloride tablet |url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=afce2787-8899-4098-87c8-f1e8dd19e6dd |access-date=2022-11-09 | work = DailyMed | publisher = U.S. National Library of Medicine }}</ref> [[landiolol]] (Japan)<ref>{{cite web|title=Announcement of Approval of Additional Indications for Onoact 50 for Injection, Short-Acting Selective ß1 Blocker|url=http://www.evaluategroup.com/Universal/View.aspx?type=Story&id=103244|website=www.evaluategroup.com|publisher=Evaluate Ltd.|access-date=18 October 2017}}</ref> * Agents specifically labeled for congestive heart failure<ref name="PharmLetter BB Table" /> ** [[Bisoprolol]], [[carvedilol]], [[metoprolol|sustained-release metoprolol]] * Agents specifically labeled for glaucoma ** [[Betaxolol]],<ref name="Aronson" /> [[carteolol]],<ref name="Aronson" /> [[levobunolol]],<ref name="Aronson" /> [[timolol]],<ref name="Aronson" /> [[metipranolol]]<ref>{{cite web|title=Metiprapanol – metipranolol solution/ drops|url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=699ce415-0798-4244-b5ec-bcdb383b50b3| work = DailyMed | publisher = U.S. National Library of Medicine – NIH|access-date=18 October 2017|url-status=live|archive-url=https://web.archive.org/web/20171018133648/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=699ce415-0798-4244-b5ec-bcdb383b50b3|archive-date=October 18, 2017|df=mdy-all}}</ref> * Agents specifically labeled for myocardial infarction<ref name="PharmLetter BB Table" /> ** [[Atenolol]], [[metoprolol]] (immediate release), [[propranolol]] (immediate release), [[timolol]], [[carvedilol]] (after left ventricular dysfunction), [[bisoprolol]] (preventive treatment before and primary treatment after heart attacks) * Agents specifically labeled for migraine prophylaxis<ref name="PL Chart Migraine">{{cite web|title=Drugs to Prevent Migraine in Adults|url=https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2012/Jul/Drugs-to-Prevent-Migraine-in-Adults-4513|website=pharmacist.therapeuticresearch.com|publisher=Therapeutic Research Center|access-date=30 April 2017|url-status=live|archive-url=https://web.archive.org/web/20171018133956/https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2012/Jul/Drugs-to-Prevent-Migraine-in-Adults-4513|archive-date=October 18, 2017|df=mdy-all}}</ref> ** [[Timolol]], [[propranolol]] [[Propranolol]] is the only agent indicated for the control of tremor, portal hypertension, and esophageal variceal bleeding, and used in conjunction with α-blocker therapy in [[phaeochromocytoma]].<ref name="Rossi"/>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)